tetano
Editor, Senior Moderator
J Med Virol
. 2022 Mar 26.
doi: 10.1002/jmv.27740. Online ahead of print.
Melatonin Use for SARS-CoV-2 Infection:Time to Diversify the Treatment Portfolio
Russel J Reiter[SUP] 1 [/SUP], Ramaswamy Sharma[SUP] 1 [/SUP], Dun Xian Tan[SUP] 1 [/SUP], Richard L Neel[SUP] 2 [/SUP], Fedor Simko[SUP] 3 [/SUP], Walter Manucha[SUP] 4 [/SUP], Sergio Rosales Corral[SUP] 5 [/SUP], Daniel P Cardinali[SUP] 6 [/SUP]
Affiliations
Abstract
We were pleased to read the publication by Lan and colleagues [1] which included a meta-analysis of the Randomized Controlled Trials (RTCs) in which melatonin was used as a treatment for COVID-19. This article is protected by copyright. All rights reserved.
Keywords: Antiviral agents; Combination therapy; Disease control; SARS coronavirus; Virus classification.
. 2022 Mar 26.
doi: 10.1002/jmv.27740. Online ahead of print.
Melatonin Use for SARS-CoV-2 Infection:Time to Diversify the Treatment Portfolio
Russel J Reiter[SUP] 1 [/SUP], Ramaswamy Sharma[SUP] 1 [/SUP], Dun Xian Tan[SUP] 1 [/SUP], Richard L Neel[SUP] 2 [/SUP], Fedor Simko[SUP] 3 [/SUP], Walter Manucha[SUP] 4 [/SUP], Sergio Rosales Corral[SUP] 5 [/SUP], Daniel P Cardinali[SUP] 6 [/SUP]
Affiliations
- PMID: 35338491
- DOI: 10.1002/jmv.27740
Abstract
We were pleased to read the publication by Lan and colleagues [1] which included a meta-analysis of the Randomized Controlled Trials (RTCs) in which melatonin was used as a treatment for COVID-19. This article is protected by copyright. All rights reserved.
Keywords: Antiviral agents; Combination therapy; Disease control; SARS coronavirus; Virus classification.